BC-201

N/A

Report date: 2025/05/27 10:08:32
NME

Base Information

Drug NameBC-201
Drug Alias NameBC-201
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionSRC inhibitorsTransmembrane protease serine 2 inhibitors
TargetsSRCTransmembrane protease serine 2
Therapy Area/IndicationsRespiratory Distress Syndrome, Adult
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBlack Cat Bio Ltd
China Registration ClassN/A

Develop Information

Active CompaniesValirx Plc
Inactive CompaniesN/A
Active IndicationsRespiratory Distress Syndrome, Adult
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A